Skip to main content

Table 1 Malignant neoplasms of 624 liver lesions diagnosed by FNB

From: Fine needle biopsy of malignant tumors of the liver: a retrospective study of 624 cases from a single institution experience

Cytologic diagnosis

Origin/site/type

Number of cases

Total number

Metastatic adenocarcinoma

  

317 (50.8%)

 

GI tract

143 (45.1%)

 
 

Pancreatobiliary

74 (23.3%)

 
 

Breast

44 (13.9%)

 
 

Lung

24 (7.6%)

 
 

GYN tract

12 (3.8%)

 
 

Kidney

12 (3.8%)

 
 

Prostate

5 (1.6%)

 
 

Thyroid

1 (0.3%)

 
 

Adrenal

2 (0.6%)

 

Hepatocellular carcinomaa

  

97 (15.5%)

Cholangiocarcinomaa

  

73 (11.7%)

Neuroendocrine neoplasm

  

58 (9.3%)

 

Well-differentiated NETs

16 (27.6%)

 
 

Poorly-differentiated NECs

42 (72.4%)

 

Squamous cell Carcinoma

  

24 (3.8%)

Lymphoma

  

17 (2.7%)

 

DLBCL

11 (64.7%)

 
 

Hodgkin lymphoma

3 (17.6%)

 
 

SLL/CLL

1 (5.9%)

 
 

Follicular lymphoma

1 (5.9%)

 
 

Multiple myeloma

1 (5.9%)

 

Sarcoma

  

11 (1.8%)

 

Leiomyosarcoma

3 (27.2%)

 
 

EBV-associated leiomyosarcomaa

1 (9.1%)

 
 

Undifferentiated pleomorphic sarcoma

2 (18.2%)

 
 

Embryonal sarcomaa

1 (9.1%)

 
 

Malignant SFT

1 (9.1%)

 
 

Myxoid liposarcoma

1 (9.1%)

 
 

GIST

2 (18.2%)

 

Melanoma

  

4 (0.6%)

Combined HCC-CCa

  

3 (0.5%)

Urothelial carcinoma

  

3 (0.5%)

Thymic carcinoma

  

2 (0.3%)

Hepatoblastomaa

  

1 (0.2%)

Paragnaglioma

  

1 (0.2%)

Mesothelioma

  

1 (0.2%)

CUP

  

12 (1.9%)

Total

  

624 (100%)

  1. aIndicate primary liver malignant lesions
  2. GI Gastrointestinal, GYN Gynecology, NETs Neuroendocrine tumors, NECs Neuroendocrine carcinomas, DLBCL Diffuse large B cell lymphoma, SLL/CLL Small lymphocytic lymphoma/Chronic lymphocytic leukemia, EBV Epstein-Barr virus, SFT Solitary fibrous tumor, GIST Gastrointestinal stroma tumor, HCC-CC Hepatocellular-cholangiocarcinoma, CUP Carcinoma of unknown primary